| Q34782210 | A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. |
| Q48292387 | Acute induration of the neck in a 16-year-old girl. |
| Q72037388 | Analysis of T-Cell Antigen Receptor Variable Region Gene Usage in Patients with Thyroid-Related Pretibial Dermopathy |
| Q77677074 | Assessment of rapid morphological changes associated with elevated cAMP levels in human orbital fibroblasts |
| Q36897408 | B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family |
| Q90264667 | Biochemically diagnosed hypothyroidism and postoperative complications after cardiac surgery: a retrospective cohort analysis |
| Q74261230 | Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy |
| Q89831182 | Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts |
| Q38727516 | Chemodenervation of extraocular muscles with botulinum toxin in thyroid eye disease |
| Q28275743 | Clinical features of Graves' ophthalmopathy in an incidence cohort |
| Q42745047 | Consequences of dysthyroidism on the digestive tract and viscera |
| Q37212791 | Correction of hypothyroidism seems to have no effect on body fat. |
| Q48144391 | Craniofacial anatomical risk factors in men with obstructive sleep apnea and heart failure: a pilot study |
| Q27691806 | Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. |
| Q34747744 | Cutaneous Manifestations of Hypothyroidism amongst Gynecological consultations |
| Q41497285 | Cytokines and thyroid function |
| Q90285496 | Delayed Breast Cellulitis following Surgery for Breast Cancer: A Literature Review |
| Q64074316 | Discrete Papular Lichen Myxedematosus and Scleromyxedema with Hypothyroidism: A Report of Two Cases |
| Q35085196 | Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease. |
| Q51370817 | Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy. |
| Q52065352 | Elevated expressionin situof selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy |
| Q87912569 | Esophagus motility in overt hypothyroidism |
| Q85853168 | Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism |
| Q42481240 | Extracellular matrix hyaluronan is a determinant of the endothelial barrier |
| Q43867818 | Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes |
| Q47615136 | From frog integument to human skin: dermatological perspectives from frog skin biology |
| Q35462752 | Glycosaminoglycans in thyroid-associated ophthalmopathy |
| Q38524606 | Graves' disease presenting as elephantiasic pretibial myxedema and nodules of the hands. |
| Q77539058 | Graves' disease presenting as localized myxedema in a thigh donor graft site |
| Q37623947 | Graves' disease. Current concepts |
| Q28274196 | Graves' ophthalmopathy |
| Q33827155 | Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease |
| Q92842093 | HYPOTHYROIDISM COULD BE A POTENTIAL FACTOR TO PROLONG SUBCUTANEOUS NODULES OF EXENATIDE ONCE WEEKLY: A CASE REPORT |
| Q50756768 | Histochemical study of cutaneous mucins in hypothyroid dogs. |
| Q40613514 | Hyaluronan metabolism in skin. |
| Q35992560 | Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor |
| Q33586738 | Increased generation of fibrocytes in thyroid-associated ophthalmopathy |
| Q36208013 | Insights into the role of fibroblasts in human autoimmune diseases. |
| Q44669559 | Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines. |
| Q36422528 | Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. |
| Q35663120 | Investigation of the choroidal thickness in patients with hypothyroidism. |
| Q36226582 | Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical site-restricted cytokine-target cell interactions. |
| Q48925100 | Lymphocytic hypophysitis: a rare cause of hypoglycaemia in a man with type 2 diabetes mellitus |
| Q71952787 | Massive ovarian enlargement in primary hypothyroidism |
| Q38710435 | Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease |
| Q58579926 | Molecular biomarkers of Graves' ophthalmopathy |
| Q24313431 | Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes |
| Q28596143 | Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases |
| Q35785137 | Novel aspects of orbital fibroblast pathology |
| Q35216491 | Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients |
| Q30994732 | PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy |
| Q36595134 | Pharmacological treatments for thyroid eye disease. |
| Q37655475 | Pitting type of pretibial edema in a patient with silent thyroiditis successfully treated by angiotensin ii receptor blockade |
| Q72001621 | Plasma glycosaminoglycans in endocrine ophthalmopathy |
| Q93177163 | Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy |
| Q35371415 | Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy |
| Q37114625 | Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation |
| Q43713870 | Relationship between interstitial fluid volume and pressure (compliance) in hypothyroid rats |
| Q37017174 | Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy. |
| Q77723435 | Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy |
| Q54736314 | Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves' orbitopathy. |
| Q36393011 | TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy |
| Q40547836 | The enigma of Graves' ophthalmopathy. |
| Q34164149 | The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota |
| Q34014939 | Thyroid associated orbitopathy following periocular surgery |
| Q39194588 | Thyroid hormone action on skin |
| Q36739708 | Thyroid hormone and wound healing. |
| Q89843708 | Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy |
| Q34147441 | Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management |
| Q33910021 | Thyroid-associated orbitopathy |
| Q37060528 | Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management. |
| Q38351966 | Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. |
| Q39196842 | Triiodothyronine (T3) inhibits hyaluronate synthesis in a human dermal equivalent by downregulation of HAS2. |
| Q72532846 | Ultrastructure of cultured human orbital fibroblasts |
| Q36951623 | Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. |